Home/Filings/4/0000899243-21-022350
4//SEC Filing

Jaws Sponsor LLC 4

Accession 0000899243-21-022350

CIK 0001800682other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 6:15 PM ET

Size

11.6 KB

Accession

0000899243-21-022350

Insider Transaction Report

Form 4
Period: 2021-06-04
Transactions
  • Other

    Class A common stock

    2021-06-04+17,175,00017,175,000 total
  • Other

    Warrants to purchase Class A common stock

    2021-06-04$1.50/sh+10,533,333$15,800,00010,533,333 total
    Exercise: $11.50From: 2021-07-04Exp: 2026-06-04Class A Common Stock (10,533,333 underlying)
  • Other

    Class B ordinary shares

    2021-06-0417,175,0000 total
    Class A Ordinary Shares (17,175,000 underlying)
Footnotes (3)
  • [F1]In connection with the consummation of the transactions contemplated by the Business Combination Agreement, dated November 11, 2020, by and among Jaws Acquisition Corp. ("Jaws"), Primary Care (ITC) Intermediate Holdings, LLC ("PCIH"), and the other parties thereto (the transactions contemplated thereby, the "Business Combination"), Jaws domesticated as a Delaware corporation (the "Domestication") and changed its name to "Cano Health, Inc." ("Cano Health"). In connection with the Domestication, the reporting person's Class B ordinary shares, par value $0.0001 per share, of Jaws, which were previously convertible into Class A ordinary shares of Jaws, were automatically converted into shares of Class A common stock of Cano Health, par value $0.0001 per share, on a one-for-one basis.
  • [F2]Pursuant to the Private Placement Warrant Purchase Agreement, dated as of May 13, 2020, by and between Jaws and the reporting person, the reporting person purchased warrants to purchase Class A ordinary shares, which following the Domestication entitle the reporting person to purchase shares of Class A common stock of Cano Health (the "Private Placement Warrants") for a price of $1.50 per Private Placement Warrant. Upon consummation of the Business Combination, the Private Placement Warrants became exercisable, beginning 30 days after the closing of the Business Combination, for one share of Class A common stock at a price of $11.50 per share. The Private Placement Warrants expire on the fifth anniversary of the consummation of the Business Combination.
  • [F3]Barry S. Sternlicht controls the reporting person, and as such has voting and investment discretion with respect to the securities held by the the reporting person and may be deemed to have beneficial ownership of the securities held directly by the reporting person.

Issuer

Cano Health, Inc.

CIK 0001800682

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001800683

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 6:15 PM ET
Size
11.6 KB